Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ko Fujimoto"'
Autor:
Takahiro Haeno, Shinya Rai, Yoshiaki Miyake, Maiko Inoue, Ko Fujimoto, Aki Fujii, Yoshio Iwata, Shuji Minamoto, Takahide Taniguchi, Hiroaki Kakutani, Hiroaki Inoue, Takahiro Kumode, Kentaro Serizawa, Yasuhiro Taniguchi, Chikara Hirase, Yasuyoshi Morita, Hirokazu Tanaka, Yoichi Tatsumi, Takashi Ashida, Itaru Matsumura
Publikováno v:
Journal of Clinical and Experimental Hematopathology.
Autor:
Ryosuke Fujiwara, Yasuhiro Taniguchi, Shinya Rai, Yoshio Iwata, Aki Fujii, Ko Fujimoto, Takahiro Kumode, Kentaro Serizawa, Yasuyoshi Morita, J. Luis Espinoza, Hirokazu Tanaka, Hitoshi Hanamoto, Itaru Matsumura
Publikováno v:
Biochemical and biophysical research communications. 626
We previously reported that the antipsychotic drug chlorpromazine (CPZ), which inhibits the formation of clathrin-coated vesicles (CCVs) essential for endocytosis and intracellular transport of receptor tyrosine kinase (RTK), inhibits the growth/surv
Publikováno v:
Internal Medicine – Open Journal. 3:9-13
Autor:
Ryota Matsuoka, J. Luis Espinoza, Yoichi Tatsumi, Ko Fujimoto, Hirokazu Tanaka, Yukie Y. Kikuti, Yasuhiro Taniguchi, Hiroaki Inoue, Yasuyoshi Morita, Naoya Nakamura, Takahiro Kumode, Shinya Rai, Takashi Ashida, Itaru Matsumura
Publikováno v:
Cancers, Vol 10, Iss 9, p 304 (2018)
Cancers
Cancers
A 62-year-old male was diagnosed with chronic lymphocytic leukemia (CLL) and treated with a fludarabine-containing regimen which maintained the disease in a partial response. Nine years after diagnosis, a rapidly growing systemic lymphadenopathy was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1aa2693d21f14673781ab493084027